We have characterized mixed chimerism (MC) in five patients with chronic myeloid leukemia
(CML) who received transplants with T-cell—depleted bone marrow (BM) and who relapsed …

After bone marrow transplantation, recipient hematopoietic cells are usually eradicated by
the combination of the cytotoxic preconditioning regimen and the allogeneic effect of the …

Recent observations of chimerism in patients relapsed following an allotransplant suggest
the persistence of immunotolerance, thus offering a biologic rationale for the use of donor …

Until now, studies on mixed chimerism (MCh) after allogeneic bone marrow transplantation
(BMT) have predominantly focused on the B-and T-lymphocyte population, but not on …

Determining both lymphoid chimerism and the presence of minimal residual disease after
allogeneic bone marrow transplantation (BMT) for chronic myelogenous leukemia (CML) …

Patients that receive a T-cell depleted (TCD) hematopoietic stem cell transplantation (SCT)
show higher risk of graft failure/rejection and of disease relapse than those that receive …

Chronic myeloid leukaemia (CML) can be treated successfully with allogeneic bone marrow
transplantation (BMT) leading to long-term disease-free survival. Leukemia relapse …

Recently, we have shown that patients with acute leukaemias and myelodysplastic
syndromes (MDS), who showed increasing mixed chimaerism (MC) upon serial PCR …

Using red cell phenotyping (RCP) and/or cytogenetics (CYT) we identified 19 patients with
persisting mixed chimerism (MC) among 231 patients transplanted with partially T cell …

We used multiplex amplification of nine microsatellite sequences (PCR-STR) to analyse
chimerism in pure populations of T cells and neutrophils from peripheral blood from 40 …